SC
Sosei CVC
Venture CapitalModerateSosei CVC is support the creation and growth of life science companies.
Tokyo, JapanFounded 2020
8
Investments
1
Exits
—
AUM
12.5%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Sosei CVC.
Investment Thesis & Strategy
Sosei CVC invests in life science companies across various stages, seeking to support their growth and development.
Investment Activity
Deals per year over the last 7 years
1
20150
20161
20172
20180
20190
20203
2021Portfolio Companies
Selected investments from their portfolio of 8 companies
A
Alentis Therapeutics
Biotech · Series A, 2021
T
T-knife Therapeutics
Biotech · Series B, 2021
I
InveniAI
AI/ML · Series B, 2021
A
Asceneuron
Biotech · Series B, 2018
E
Evotec
Biotech · Growth, 2018
i
iTeos Therapeutics
Biotech · Series A, 2017
V
Vaximm
Biotech · Series B, 2015
Frequently Asked Questions
Sosei CVC focuses on Series A, Series B, Series C+ stage investments.